Clinician's Roundtable

Misconceptions around irritable bowel syndrome with diarrhea (IBS-D) can contribute to significant gaps in care and unmet patient needs. Primary care providers play a crucial role in addressing these needs and ensuring an accurate diagnosis. To learn more about best practices for diagnosing and communicating with patients, Dr. Brian McDonough sits down with Dr. Holly Greenwald, Assistant Professor of Clinical Medicine at Temple University Lewis Katz School of Medicine.

Salix Pharmaceuticals
400 Somerset Corporate Blvd.
Bridgewater, NJ 08807
© 2025 Salix Pharmaceuticals or its affiliates. MED-US-NPR-0048

For patients with IBS-D, the stigma surrounding the condition can make it difficult to openly discuss their symptoms and accept their diagnosis. Providing reassurance and a clear path forward can help create a supportive and comfortable environment for these patients. To learn more about how we can destigmatize IBS-D, Dr. Brian McDonough sits down with Dr. Paul Doghramji, who’s the Medical Director of Health Services at Ursinus College and a physician at Collegeville Family Practice and Pottstown Memorial Medical Center.

Salix Pharmaceuticals
400 Somerset Corporate Blvd.
Bridgewater, NJ 08807
© 2025 Salix Pharmaceuticals or its affiliates. MED-US-NPR-0053

For patients with psoriasis, the most effective therapy is not always accessible. Considering patient-specific factors, including overall health, can help create a holistic treatment plan. Tune in to hear from Dr. Robert Gniadecki, Professor and Director of the Division of Dermatology at the University of Alberta, as he discusses best practices for tailoring psoriasis management.

For patients with hidradenitis suppurativa, treatment varies by stage. Topicals, antibiotics, biologics, and procedural interventions can all play a role in management depending on symptoms and severity. Learn more as Dr. Daniel Klufas, an Assistant Professor of Dermatology at the University of California, San Francisco discusses current options and best practices for optimal care.

Early diagnosis and prompt intervention in hidradenitis suppurativa patients are essential to preventing long-term impacts. With emerging treatments on the horizon, the future of hidradenitis suppurativa care is promising. Dr. Daniel Klufas, an Assistant Professor of Dermatology at the University of California, San Francisco, provides insight into the future of diagnosis and treatment.

Hidradenitis suppurativa is a chronic skin condition characterized by painful abscesses, sinus tracts, and immune dysregulation. Dr. Daniel Klufas, an Assistant Professor of Dermatology at the University of California, San Francisco, explains the symptoms, impacts, and unmet needs associated with the disease.

Chronic hand eczema (CHE) can have vast impacts on a patient’s personal and professional life, making the overall patient journey one of the most important considerations for clinicians. That’s why Dr. Jeff Yu joins Dr. Raj Chovatiya to share best practices for diagnosing and treating patients with CHE so we can optimize their journey. Dr. Yu is an Associate Professor at the Rosalind Franklin University Chicago Medical School.

The underlying mechanisms behind chronic hand eczema (CHE) can lead to a variety of physical, emotional, social, and occupational challenges. To learn more about these challenges, Dr. Raj Chovatiya sits down with Dr. Benjamin Ehst to discuss what we currently know about the pathophysiology of CHE and what we can do to address patients’ unmet needs. Dr. Ehst is a dermatologist at Broadway Medical Clinic and an investigator at the Oregon Medical Research Center.

Here to share a glimpse into where the dermatology field might be headed based on updates from the Maui Derm 2025 conference is Dr. Raj Chovatiya. Dr. Chovatiya is a Clinical Associate Professor at the Rosalind Franklin University Chicago Medical School and Founder and Director of the Center for Medical Dermatology and Immunology Research in Chicago.

Here to share his insights on the key themes and topics covered at the Maui Derm 2025 conference is Dr. Raj Chovatiya. Dr. Chovatiya is a Clinical Associate Professor at the Rosalind Franklin University Chicago Medical School and Founder and Director of the Center for Medical Dermatology and Immunology Research in Chicago.